IQVIA Vigilance Detect is an AI-driven pharmacovigilance platform designed to monitor the expanding use of GLP-1 therapies. It identifies adverse events, product quality complaints, and off-label use across audio, email, chatbot logs, and scanned documents. With 99% transcription accuracy, the platform reduces manual workload and enhances regulatory compliance.